All Biotechnology articles
View all stories with this category.
-
Research’This is just the beginning’: RNA editing set to democratise viral engineering
Crispr-based system could ease development of novel RNA therapies
-
ResearchChemical industry hasn’t yet developed an appetite for biocatalysis, survey finds
Misconceptions along with a lack of time and resources driving industry’s reluctant attitude to biocatalysis and chemoenzymatic catalysis
-
ResearchSynthetic peptide mimics can act as antivirals
Peptoids disrupt enveloped viruses’ lipid membranes as well as targeting fungi and bacteria
-
NewsJustice for Henrietta Lacks as family reaches settlement with Thermo Fisher
Company was accused of profiting from HeLa cells derived from Lacks’ tumour without her family’s approval
-
ResearchClick chemistry offers new, efficient process to produce unique cancer-fighting antibodies
Chemical approach is fast and flexible and could be an alternative o using protein engineering
-
BusinessAntibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?
-
BusinessBiogen to cut 1000 more jobs by 2025
Biotech giant has also agreed to buy Reata Pharmaceuticals for $7.3 billion
-
ResearchProtein folding stability set to be unravelled on a massive scale
Technique can analyse a million protein sequences at a time to provide data for machine learning models
-
ResearchCrispr editing reduces poplar lignin content
Gene-edited wood could reduce waste and save energy during pulping process
-
ResearchAir monitor detects airborne virus particles in real time
Device that detects Sars-CoV-2 could be adapted to monitor other respiratory pathogens
-
NewsEuropean Commission set to propose an overhaul of rules for gene-edited crops
Leaked document reveals light touch regulation planned for crops engineering using precision techniques
-
ResearchLateral flow HPV test could increase detection rates in resource-poor settings
Low-cost assay works uses self-collected samples and gives results within 45 minutes
-
ResearchBiocatalytic process shows promise for large-scale medicinal oligonucleotide production
Promising nucleic acid therapies could be made more cheaply, greenly and simply
-
NewsBillionaire professor donates ‘transformative’ sum to protein science institute
$210 million endowment from entrepreneur and Moderna investor Tim Springer will support ongoing research
-
BusinessUS supreme court confirms Amgen’s cholesterol antibody patents invalid
Decision could mean patent descriptions need to be even more detailed, and hence expensive
-
ResearchCarbene chemistry built into microbe’s metabolism in first for biosynthesis
Proof-of-concept work opens pathway to bacteria engineered to synthesise new-to-nature products
-
NewsThe launch of a new field: precision microbiome editing
Nobel laureate Jennifer Doudna is helping lead a new $70 million project combining metagenomics and CRISPR to solve health, climate problems
-
ResearchBiocatalytic biobots brew beer better
Encapsulated yeast and iron nanoparticles enhance beer fermentation through self-propelled oscillatory motion and easy magnetic retrieval
-
BusinessMerck & Co to buy immunology specialist Prometheus
$10.8 billion cash deal give Merck rights to late-stage candidate for two inflammatory bowel conditions
-
BusinessGhana and Nigeria approve Oxford malaria vaccine
Approval comes before final-stage clinical trials have been completed